About a week ago, FDA approved the very first treatment for patients with liver fibrosis caused by fatty liver disease.
Rezdiffra (resmetirom) is now approved for treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), […]

Here are some of the things that makes our data unique:

1. Fast access to comprehensive data
In January 2024, the processing time at the Danish Health Data Authority decreased to just 34.9 days, providing swift access to a wealth of national-level […]

Recently, the 2023 ratings of Swedish Quality of care registers were made official and there are many top-rated registries within fields such as oncology, cardiovascular disease, infectious diseases, CNS and musculoskeletal diseases to name a few.

The Swedish disease-specific Quality of […]

Two renewed electronic catalogues of real-world data (RWD) sources and studies to enhance data discoverability have recently been launched by EMA and Heads of Human Medicines.

👉 The Catalogue of RWD Sources replaces the ENCePP Resources Database, offering a centralised repository […]

·      What is it?
JCA is a streamlined EU-level process that evaluates the relative effectiveness and safety of new treatments compared to a range of alternative treatments. It considers a range of relevant treatments across EU member states. The […]

As the number one provider of Nordic registry studies, Quantify sits at the heart of Scandinavia.

The Nordics typically refers to Northern European countries with similar history, culture and social structures.
They include Denmark, Finland, Iceland, Norway and Sweden plus some autonomous […]

It’s been a great day at SCOPE summit! In addition to joining in many excellent seminars, we’ve had a great exchange of ideas about how Nordic data can support regulatory decision making and clinical development objectives.

Come visit us tomorrow at […]

Quantify’s Partner Anders Gustavsson and other Alzheimer’s experts recently shared their perspectives after a symposium at Karolinska Institutet.

Preparing for the introduction of disease modifying treatments in Alzheimer’s disease implies several challenges to patient identification, treatment […]

Don’t miss it!

Next week, Quantify’s CEO Kirk Geale and Head of RWE Emilie Toresson Grip are headed to Orlando, FL for the annual SCOPE Summit where the Quantify […]